These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27237029)

  • 1. DNMT3a expression pattern and its prognostic value in lung adenocarcinoma.
    Husni RE; Shiba-Ishii A; Iiyama S; Shiozawa T; Kim Y; Nakagawa T; Sato T; Kano J; Minami Y; Noguchi M
    Lung Cancer; 2016 Jul; 97():59-65. PubMed ID: 27237029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
    Sakurai H; Asamura H; Miyaoka E; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):100-7. PubMed ID: 23729748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
    Xu Y; Zhu C; Qian W; Zheng M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):181-186. PubMed ID: 27738759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.
    Calvayrac O; Pradines A; Raymond-Letron I; Rouquette I; Bousquet E; Lauwers-Cances V; Filleron T; Cadranel J; Beau-Faller M; Casanova A; Milia J; Favre G; Mazières J
    Clin Cancer Res; 2014 Dec; 20(24):6541-50. PubMed ID: 25320360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
    Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
    Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
    Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
    J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
    Kataoka I; Funata S; Nagahama K; Isogaya K; Takeuchi H; Abe N; Shibahara J
    Ann Diagn Pathol; 2020 Feb; 44():151456. PubMed ID: 31862523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
    Wu PF; Kuo KT; Kuo LT; Lin YT; Lee WC; Lu YS; Yang CH; Wu RM; Tu YK; Tasi JC; Tseng HM; Tseng SH; Cheng AL; Lin CH
    Lung Cancer; 2010 Jun; 68(3):484-90. PubMed ID: 19740564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophilin A expression and its prognostic significance in lung adenocarcinoma.
    Nakano N; Sakashita S; Matsuoka R; Murata Y; Shiba-Ishii A; Kobayashi N; Sato Y; Noguchi M
    Pathol Int; 2017 Nov; 67(11):555-563. PubMed ID: 29027312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geminin expression in small lung adenocarcinomas: implication of prognostic significance.
    Haruki T; Shomori K; Hamamoto Y; Taniguchi Y; Nakamura H; Ito H
    Lung Cancer; 2011 Mar; 71(3):356-62. PubMed ID: 20650542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
    Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
    Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma.
    Guo Z; Yi F; Yin W; Zhang Y; Li Q; Gu Y; Xiao Y; Cao B; Ma L; Liang L
    Thorac Cancer; 2017 May; 8(3):159-169. PubMed ID: 28220630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.